Alvaro Ballesteros

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Pharmacokinetics and pharmacodynamics of valganciclovir in infants with severe HIV-associated pneumonia in Africa: a sub-study of the EMPIRICAL randomised controlled trial.

Pharmacokinetics and pharmacodynamics of valganciclovir in infants with severe HIV-associated pneumonia in Africa: a sub-study of the EMPIRICAL randomised controlled trial.

Journal: EClinicalMedicine

Published: January 08, 2026

Empirical treatment with valganciclovir in infants living with HIV and hospitalised with severe pneumonia in Africa: a multicentre, open-label, factorial, randomised, controlled, superiority trial.

Empirical treatment with valganciclovir in infants living with HIV and hospitalised with severe pneumonia in Africa: a multicentre, open-label, factorial, randomised, controlled, superiority trial.

Journal: Lancet (London, England)

Published: December 11, 2025

Short- and Long-term Humoral Response of Immunosuppressed Children to SARS-CoV-2 BNT162b2 Vaccine.

Short- and Long-term Humoral Response of Immunosuppressed Children to SARS-CoV-2 BNT162b2 Vaccine.

Journal: The Pediatric infectious disease journal

Published: December 05, 2025

Comorbidities Associated With Different Degrees of Severity in Children and Young People Hospitalized With Acute COVID-19.

Comorbidities Associated With Different Degrees of Severity in Children and Young People Hospitalized With Acute COVID-19.

Journal: The Pediatric infectious disease journal

Published: January 10, 2025

Persistent Symptoms (Lasting Longer than 1 Year) in Children Hospitalized with Acute COVID-19 Versus Other Conditions.

Persistent Symptoms (Lasting Longer than 1 Year) in Children Hospitalized with Acute COVID-19 Versus Other Conditions.

Journal: Children (Basel, Switzerland)

Published: October 03, 2024

Statistical analysis plan for the "empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia" clinical trial.

Statistical analysis plan for the "empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia" clinical trial.

Journal: Trials

Published: May 10, 2024

High mortality following early initiation of antiretroviral therapy in infants living with HIV from three African countries.

High mortality following early initiation of antiretroviral therapy in infants living with HIV from three African countries.

Journal: EClinicalMedicine

Published: January 15, 2024

Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial.

Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: July 21, 2023

First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia.

First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia.

Journal: Journal of the Pediatric Infectious Diseases Society

Published: July 11, 2023

Testing the performance, adequacy, and applicability of an artificial intelligence model for pediatric pneumonia diagnosis.

Testing the performance, adequacy, and applicability of an artificial intelligence model for pediatric pneumonia diagnosis.

Journal: Computer methods and programs in biomedicine

Published: March 24, 2023

Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change.

Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: November 10, 2022

Manifestations and clinical phenotypes are not specific enough to predict SARS-CoV-2 infection in symptomatic children.

Manifestations and clinical phenotypes are not specific enough to predict SARS-CoV-2 infection in symptomatic children.

Journal: Acta paediatrica (Oslo, Norway : 1992)

Published: February 04, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026